FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Illumina's Free Cash Flow for the
three
months ended in Dec. 2023 was $173 Mil. Illumina's Revenue for the
three
months ended in Dec. 2023 was $1,122 Mil. Therefore, Illumina's FCF Margin % for the quarter that ended in Dec. 2023 was 15.42%.
As of today, Illumina's current FCF Yield % is 1.46%.
The historical rank and industry rank for Illumina's FCF Margin % or its related term are showing as below:
ILMN'
s FCF Margin % Range Over the Past 10 Years
Min: -1.61 Med: 20.82 Max: 28.96
Current: 6.26
During the past 13 years, the highest FCF Margin % of Illumina was 28.96%. The lowest was -1.61%. And the median was 20.82%.
ILMN's FCF Margin % is ranked better than 70.22% of 225
companies
in the Medical Diagnostics & Research industry
Industry Median: -10.75
vs ILMN: 6.26
Illumina FCF Margin % Historical Data
The historical data trend for Illumina's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Illumina Annual Data
Trend
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Dec22
Dec23
FCF Margin %
23.77
27.51
7.45
-1.61
6.26
Illumina Quarterly Data
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Sep22
Dec22
Mar23
Jun23
Sep23
Dec23
FCF Margin %
5.45
-3.96
4.93
8.40
15.42
Competitive Comparison
For the Diagnostics & Research subindustry, Illumina's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Illumina FCF Margin % Distribution
For the Medical Diagnostics & Research industry and Healthcare sector, Illumina's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Illumina's FCF Margin % falls into.
Illumina FCF Margin % Calculation
FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.
Illumina's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Illumina FCF Margin % Related Terms
Thank you for viewing the detailed overview of Illumina's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates about 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (about 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ILMN has been successfully added to your 